Walmart’s latest brand and logo update has left some social media users baffled. On Jan. 13, the company announced in a press release on its website that it was launching a “comprehensive ...

Wunjo CE: Face Swap, Lip Sync, Control Remove Objects & Text & Background, Restyling, Audio Separator, Clone Voice, Video Generation. Open Source, Local & Free.

🖼️ Image Toolbox is a powerful app for advanced image manipulation. It offers dozens of features, from basic tools like crop and draw to filters, OCR, and a wide range of image processing options ...

ABU DHABI, Jan 23 (Reuters) - Abu Dhabi's M42, an artificial intelligence (AI)-powered healthcare company backed by sovereign wealth fund Mubadala, announced a new operating structure on Thursday ...

Capital One Venture Rewards Credit Card: Best for Simple travel rewards Bank of America® Travel Rewards credit card: Best for Simple rewards + no annual fee Capital One Quicksilver Cash Rewards ...

KELIX Bio, a subsidiary of Mubadala Investment Company, has completed its acquisition of DiabTec, a biomanufacturing facility previously owned by Julphar, one of the UAE’s largest pharmaceutical ...

Did you confront him about his dealings in 1MDB? Najib: I asked him, ‘where did you get all these’, he said ‘No, no, no, I’m doing it for Sheikh Mansour’, that’s what he said, you know, ‘Sheikh ...

Kelix bio, an emerging markets-focused specialty generic biopharmaceutical company has struck its fifth strategic deal since its acquisition by Abu Dhabi sovereign investor Mubadala Investment Company ...

In September, the Turkish competition board said Mubadala had applied to take sole control of Getir, though no further details had since been given. The company, a pioneer of fast grocery delivery ...

KELIX bio, wholly owned by Mubadala Investment Company, an Abu Dhabi sovereign investor, has completed the acquisition of DiabTec LLC, a subsidiary of Julphar. This acquisition strengthens ...

UAE - Kelix bio, wholly owned by Mubadala Investment Company, an Abu Dhabi sovereign investor, has completed the acquisition of DiabTec, a subsidiary of Julphar. This acquisition strengthens ...

Getir’s founding team had previously clashed with investors, primarily Mubadala, over the company’s strategy and costs. Its valuation plunged to $2.5 billion in 2023 from its peak of $11.8 ...